TEAM

MEET OUR TEAM

Jeff Lawson, MD, PhD
Physician-Scientist, Inventor, Entrepreneur, Innovator, and Investor

  • Professor of Surgery, Duke University with 20+ years of clinical practice and scientific research in vascular surgery and biology, including Chief of Vascular Surgery

  • President and CEO, MedBlue Incubator

  • Founder, Chief Medical Officer, and CEO, Humacyte, Inc. (NASDAQ: HUMA); public listing in 2021 through a merger with Alpha Healthcare Acquisition Corp. (SPAC)

  • Founder and CEO, Innavasc, Inc. (sold to Gore Medical; 10X investor return)

  • Raised $200M+ in translational research funding and $100M in peer-reviewed grants

  • MD and PhD (Cellular and Molecular Biology) – University of Vermont

Blake Long, MD, MBA
Entrepreneurial Physician, Seasoned Health Care Executive, and Investor

  • 20+ years of clinical practice as a pediatric cardiologist, including Chair of Pediatrics

  • COO, MedBlue Incubator

  • Adjunct Professor Duke University Fuqua School of Business

  • Chief Medical / Clinical Officer - ALVA10, Sapere Bio, Echo Health Ventures, Mosaic Health

  • Ariel Southeast Angel Partners – Investor and member of life sciences diligence team

  • 24th Infantry Division, US Army 

  • MD, MBA, and BA (Economics) – Duke University

TEAM

WHAT MAKES US UNIQUE

Unmatched Clinical Insight - With over two decades at the front lines of vascular surgery and interventional cardiology, we don’t theorize about healthcare—we’ve lived it. We understand, firsthand, how drugs, devices, diagnostics, and imaging perform in real clinical settings.

True Multidisciplinary Advantage - We operate at the intersection of biology, engineering, medicine, and business—giving us the ability to cut through complexity, identify real innovation, and systematically de-risk investments others can’t evaluate with confidence.

Ahead of the Curve - We see where medicine is going before the market does. Our deep understanding of unmet clinical needs and evolving healthcare systems allows us to identify breakthrough ideas and high-impact investment opportunities early.

Network Effects That Matter - We are deeply embedded in a trusted, high-value network of physicians, scientists, engineers, founders, and investors. This isn’t passive access—it’s an active ecosystem that generates proprietary insights, differentiated deal flow, and meaningful collaboration.

Relentless Execution - We are disciplined, selective, and unapologetically focused on outcomes. We invest on our terms, stay actively involved, and are willing to make hard decisions—including shaping strategy and leadership—to drive companies to successful exits.